Facebook
Twitter
LinkedIn
ForwardImproving Outcomes in OAB: New and Emerging Strategies to Reduce Symptom Burden and Treatment Adverse Effects (Archived CME/CE Monograph)
This educational activity will review efficacy, safety, and tolerability data for overactive bladder pharmacologic therapies, including a new β3-adrenoceptor agonist, and their relevance for counseling to improve treatment adherence.
Improving Outcomes in OAB: New and Emerging Strategies to Reduce Symptom Burden and Treatment Adverse Effects (Archived CME/CE Webcast)
This educational activity will review the efficacy, safety, and tolerability data for overactive bladder pharmacologic therapies, including current and emerging β3-adrenoceptor agonists.
Improving Outcomes in OAB: New and Emerging Strategies to Reduce Symptom Burden and Treatment Adverse Effects (Archived CME/CE Webcast)
This educational activity will review the efficacy, safety, and tolerability data for overactive bladder pharmacologic therapies, including current and emerging β3-adrenoceptor agonists.
New Treatment Strategies and Considerations in OAB to Improve Patient Outcomes (Archived Online CME/CE Monograph)
This educational activity is based on the proceedings of several symposia on OAB that reviewed updates in the treatment of OAB, including clinical data on new and emerging treatments, and which highlighted some of the evidence on the increased risk of dementia associated with antimuscarinic use.
New Treatment Strategies and Considerations in OAB to Improve Patient Outcomes (Archived CME/CE Webcast)
This educational activity is based on the proceedings of a symposium held in conjunction with the 95th Annual Meeting of the North Central Section of the American Urological Association on OAB that reviewed updates in the treatment of OAB, including clinical data on new and emerging treatments, and which highlighted some of the evidence on the increased risk of dementia associated with antimuscarinic use.
New Treatment Strategies and Considerations in OAB to Improve Patient Outcomes (Archived CME/CE Webcast)
This educational activity is based on the proceedings of a symposium held in conjunction with the 2021 Annual Meeting of the American Urological Association on OAB that reviewed updates in the treatment of OAB, including clinical data on new and emerging treatments, and which highlighted some of the evidence on the increased risk of dementia associated with antimuscarinic use.
Case Discussions in OAB, BPH, and More: Managing the Complex Patient (CME/CE Monograph)
This educational activity provides an in-depth look at managing overactive bladder, with a focus on treating complex patients.